DZ2077A1 - Novel method for formulating solid dosage forms, and dosage forms produced thereby. - Google Patents

Novel method for formulating solid dosage forms, and dosage forms produced thereby.

Info

Publication number
DZ2077A1
DZ2077A1 DZ960121A DZ960121A DZ2077A1 DZ 2077 A1 DZ2077 A1 DZ 2077A1 DZ 960121 A DZ960121 A DZ 960121A DZ 960121 A DZ960121 A DZ 960121A DZ 2077 A1 DZ2077 A1 DZ 2077A1
Authority
DZ
Algeria
Prior art keywords
dosage forms
novel method
produced
formulating solid
solid dosage
Prior art date
Application number
DZ960121A
Other languages
French (fr)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2077A1 publication Critical patent/DZ2077A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ960121A 1995-07-29 1996-07-27 Novel method for formulating solid dosage forms, and dosage forms produced thereby. DZ2077A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
DZ2077A1 true DZ2077A1 (en) 2002-07-22

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960121A DZ2077A1 (en) 1995-07-29 1996-07-27 Novel method for formulating solid dosage forms, and dosage forms produced thereby.

Country Status (25)

Country Link
EP (1) EP0841902A2 (en)
JP (1) JPH11510493A (en)
KR (1) KR19990035972A (en)
CN (1) CN1196677A (en)
AP (1) AP858A (en)
AR (1) AR004178A1 (en)
AU (1) AU716961B2 (en)
BG (1) BG102266A (en)
BR (1) BR9609804A (en)
CA (1) CA2228048A1 (en)
CZ (1) CZ24798A3 (en)
DZ (1) DZ2077A1 (en)
EA (2) EA199901055A1 (en)
HU (1) HUP9900521A3 (en)
IL (1) IL122897A0 (en)
MA (1) MA23953A1 (en)
MX (1) MX9800809A (en)
NO (1) NO980384L (en)
NZ (1) NZ315632A (en)
OA (1) OA10659A (en)
PL (1) PL325242A1 (en)
SK (1) SK11098A3 (en)
TR (1) TR199800156T1 (en)
UY (1) UY24297A1 (en)
WO (1) WO1997004750A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
AU748396C (en) * 1998-03-11 2003-01-23 Smithkline Beecham Corporation Composition
FR2796840B1 (en) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
BRPI0116793B8 (en) 2000-12-14 2021-05-25 Johnson & Johnson Steroid hormone products and methods to prepare them
WO2005097076A2 (en) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Low dose pharmaceutical products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (en) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd Wet solid pharmaceutical preparation of very small amount of main drug
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
SG48315A1 (en) * 1989-04-13 1998-04-17 Beecham Group Plc Novel compounds
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
CZ24798A3 (en) 1998-06-17
MA23953A1 (en) 1997-04-01
NO980384L (en) 1998-03-26
NZ315632A (en) 1999-11-29
HUP9900521A3 (en) 2001-04-28
JPH11510493A (en) 1999-09-14
AU6738496A (en) 1997-02-26
HUP9900521A2 (en) 1999-06-28
WO1997004750A2 (en) 1997-02-13
AP9801170A0 (en) 1998-01-31
MX9800809A (en) 1998-04-30
PL325242A1 (en) 1998-07-06
IL122897A0 (en) 1998-08-16
OA10659A (en) 2002-09-18
BR9609804A (en) 1999-07-06
AU716961B2 (en) 2000-03-09
AP858A (en) 2000-07-12
TR199800156T1 (en) 1998-04-21
KR19990035972A (en) 1999-05-25
CN1196677A (en) 1998-10-21
EA000740B1 (en) 2000-02-28
EA199901055A1 (en) 2000-06-26
CA2228048A1 (en) 1997-02-13
AR004178A1 (en) 1998-11-04
UY24297A1 (en) 1997-01-23
NO980384D0 (en) 1998-01-28
EP0841902A2 (en) 1998-05-20
EA199800179A1 (en) 1998-10-29
BG102266A (en) 1998-10-30
SK11098A3 (en) 1998-07-08
WO1997004750A3 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
MA26410A1 (en) PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PRODUCTION.
HK1019858A1 (en) Process for forming solid oral dosage forms of valsartan.
TR199600792A2 (en) Process for the preparation of dihaloazolopyrimidines.
FR2685916B1 (en) MIXED NO SYNTHASE AND CYCLOOXYGENASE INHIBITORS AND A PROCESS FOR THEIR PREPARATION.
MA26508A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE, AND PROCESS FOR THEIR PREPARATION.
HUP0000214A3 (en) Alpha-substituted benzenesulphonamido hydroxamic acids, process for their preparation and pharmaceutical compositions containing them
MA26431A1 (en) PROCESS FOR THE PREPARATION OF ARYLPYRIMIDINES, THEIR USE FOR THE PREPARATION OF MEDICAMENTS AND FOR THE TREATMENT OF A MAMIFER WHICH MAY BE ATTENUATED BY TREATMENT WITH 5HT2B ANTAGONIST
DZ2074A1 (en) New formulation containing paroxetine, and process for its preparation.
DZ2114A1 (en) Process for the preparation of (-) - cis-6 (s) -phenyl-5} 4- (2-pyrrolidine-1-ylethoxy) -phenylÜ-5,6,7,8-tetrahydronaphthalene-2- d-tartrate ol.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
NO981800L (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
MA25418A1 (en) PROCESS FOR PRODUCING RAPIDLY DECOMPOSABLE SOLID PHARMACEUTICAL PREPARATIONS.
FR2707087B1 (en) New process for the preparation of ergothionein.
DZ1910A1 (en) New streptogramins and method for preparing streptogramins by mutasynthesis.
NO974169D0 (en) Process for tetra-azacycloalkane preparation
FR2714063B1 (en) Process for the preparation of collagen from cnidarians, and compositions obtained which can be used in cosmetics.
DZ2077A1 (en) Novel method for formulating solid dosage forms, and dosage forms produced thereby.
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
HUP9602748A2 (en) Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
FR2700956B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITION AND PROCESS FOR ITS PREPARATION.
HU9503932D0 (en) Substituted benzol-sulfonyl-ureas and-thioureas, pharmaceutical compositions containing them and process for producing them
HUP9802571A3 (en) Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles, process for their preparation and pharmaceutical compositions containing them
HUP9702395A3 (en) Prokinetic oxadiazoles, process for their preparation, intermediates and pharmaceutical compositions containing the same